First Commonwealth Financial Corp Bristol Myers Squibb CO Transaction History

First Commonwealth Financial Corp

$400 Million
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $59,207 - $77,948	-1,471 Reduced 11.07%	11,815 $490,000
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $414,499 - $469,961	8,639 Added 185.9%	13,286 $720,000
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $153,681 - $183,384	-3,170 Reduced 40.55%	4,647 $238,000
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $31,472 - $34,945	494 Added 6.75%	7,817 $499,000
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $14,587 - $16,545	-222 Reduced 2.94%	7,323 $507,000
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $39,170 - $46,383	-572 Reduced 7.05%	7,545 $542,000
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $117 - $69,232	-901 Reduced 9.99%	8,117 $577,000
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $639,927 - $704,783	-8,812 Reduced 49.42%	9,018 $695,000
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $27,051 - $32,436	440 Added 2.53%	17,830 $1.3 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $1,340 - $1,563	25 Added 0.14%	17,390 $1.08 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $8,757 - $10,257	-148 Reduced 0.85%	17,365 $1.03 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $31,945 - $34,788	516 Added 3.04%	17,513 $1.17 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $133,871 - $150,565	-2,256 Reduced 11.72%	16,997 $1.07 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $205,669 - $233,061	-3,562 Reduced 15.61%	19,253 $1.19 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $191,414 - $212,112	3,333 Added 17.11%	22,815 $1.38 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $124,276 - $145,292	2,267 Added 13.17%	19,482 $1.15 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $140,684 - $204,447	3,032 Added 21.38%	17,215 $960,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $2,608 - $3,402	53 Added 0.38%	14,183 $910,000
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $178,992 - $212,221	4,185 Added 42.08%	14,130 $716,000
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $252,593 - $279,313	5,661 Added 132.14%	9,945 $451,000
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $20,304 - $24,210	-450 Reduced 9.51%	4,284 $205,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $99,811 - $129,431	-2,047 Reduced 30.19%	4,734 $246,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $242,394 - $273,402	-4,392 Reduced 39.31%	6,781 $421,000
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $5,457 - $6,801	-108 Reduced 0.96%	11,173 $618,000
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $459,166 - $528,593	7,663 Added 211.8%	11,281 $714,000
Q4 2017 Feb 15, 2018	SELL	$59.94 - $65.35 $138,101 - $150,566	-2,304 Reduced 38.91%	3,618 $222,000
Q3 2017 Nov 13, 2017	SELL	$55.23 - $63.74 $150,225 - $173,372	-2,720 Reduced 31.47%	5,922 $377,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,642	8,642 $482,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Commonwealth Financial Corp , based on Form 13F filings with the SEC.

News

Stay updated on First Commonwealth Financial Corp with notifications on news.

Account